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Article info ABSTRACT  
One of the promising and quite new directions of non-invasive prenatal 
diagnostics can be the analysis of extracellular fetal DNA in the blood 
of pregnant women. Objective: determination of prognostic significance 
of fetal DNA level in prognosis of fetal pathology. Material and 
Methods: seventeen pregnant women with fetal pathology in the second 
trimester were examined in the dynamics of gestation in obstetric 
complex No. 9 in Tashkent. Control group included 29 pregnant women 
with physiological course of gestation and without pathology. Results: 
the concentration of fetal DNA in plasma of pregnant women with fetal 
malformations in the second trimester exceeds the indicators of 
pregnant women without fetal pathology in 1.8 times. The total 
concentration associated with the surface of cells of fetal DNA in 2.3 
times higher than in women without fetal pathology. The maternal DNA 
in fetal pathology was significantly decreased (in 3.1 times) in the 
fraction associated with the surface of blood cells, whereas the level of 
the mother’s DNA in plasma from pregnant women with fetal 
abnormalities was lower in 1.7 times, in comparison with pregnant 
women without fetal pathology. The analysis of correlation between 
fetal and maternal extracellular DNA showed that this relationship is 
higher in the plasma and in the fraction associated with ionic 
interactions than in the fraction of extracellular DNA associated with 
cell surface proteins as in the physiological course of pregnancy, as in 
fetal abnormalities. Conclusions: the obtained results allow concluding 
that to increase the informative value of non-invasive diagnosis of fetal 
pathology at different stages of pregnancy, it seems appropriate to use 
fractions of fetal and maternal extracellular DNA associated with the 
surface of blood cells of the mother. 
 
Introduction. In the last time, due to the high incidence of viral infections among 
the population, interest in viruses and their role in the genesis of reproductive losses is 
growing. In acute viral infections, intrauterine infection of the fetus and placental damage 
often occur [1]. In recent years, there has been an increase in the incidence of acute 
respiratory viral infections (ARVI) in pregnant women, reaching 35.6% [2], which 
adversely affects the course and outcome of pregnancy.  
There is very inconsistent evidence that ARVI in the mother may increase the risk 
of certain congenital malformations in children such as hydrocephalus, esophageal atresia 
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or anophthalmia/microphthalmia [3, 4]. There are cases of increased risk of anencephaly 
because of flu epidemic in the United States and Asia [5, 6].  
A case-control study of congenital developmental anomalies in Hungary 
demonstrates the relationship between ARVI in the mother in the second and third 
months of pregnancy and congenital malformations in the child, such as cleft lip or 
palate, neural tube defect and cardiovascular malformations [7]. 
A case-control study, involving 363 neonates with neural tube defect and 523 
healthy children, revealed that an increased risk of this disease was associated with ARVI 
in the mother [8]. In a number of case-control trials, the association between diseases in 
the mother and high risk of congenital defects [9]. In the literature, there is insufficient 
information about the course of gestation and complications from the fetus, depending on 
the duration of pregnancy and the severity of course of the infectious process. 
The significance of the level of fetal DNA as a predictive marker in pregnant 
women with fetal pathology remains practically unexplored that determines the urgency 
of the problem and necessity for targeted research in this direction. 
The need for developing new methods for non-invasive diagnosis of fetal 
development disorders is dictated by the following reasons. On the one hand, genetic 
analysis of fetal material obtained by invasive procedures reflects the true chromosome 
status of fetal cells with high accuracy; on the other hand, such manipulations involve a 
risk of abortion. The available non-invasive methods of prenatal diagnosis of 
chromosomal pathology are safe for maternal and fetal health; however, their 
informativeness does not exceed 60% [10, 11, 12]. 
One of the promising and quite new directions of noninvasive prenatal diagnostics 
can be the analysis of extracellular fetal DNA in the blood of pregnant women. In 1997, 
for the first time, the presence of fetal extracellular DNA in the serum of pregnant 
women was determined [13, 14]. 
This discovery stimulated intensive study of fetal DNA as a marker for non-
invasive prenatal diagnosis. However, until now, the reason for the increase in the 
concentration of extracellular fetal DNA in the blood of women bearing fetuses with 
intrauterine growth disorders remains unclear. Obtaining new data on the peculiarities of 
DNA circulation in fetal developmental anomalies will make it possible to evaluate the 
possibility of analyzing extracellular fetal DNA as a marker of non-invasive prenatal 
diagnosis. 
Materials and Methods 
Pregnant women were examined in the dynamics of gestation in obstetric complex 
No. 9 in Tashkent. The main group consisted of 17 pregnant women with fetal pathology 
in the second trimester. Control group included 29 pregnant women with physiological 
course of gestation and without pathology. The average age of women was 26.3 ± 0.5 
years. 
The method for measuring the concentration of fetal DNA in the mother’s blood 
was to carry out quantitative real-time PCR. In order to evaluate the features of 
circulation of extracellular DNA in the blood of pregnant women in the second trimester 
of pregnancy, the levels and ratio of fractions of freely circulating in plasma and cell-
bound DNA were analyzed. The material was taken with the informed consent of the 
pregnant women participating in the study. 
Results and Discussion 
We conducted analysis of correlation between fetal and maternal extracellular DNA 
in the blood of pregnant women bearing healthy fetuses and those with violations of 
2
Central Asian Journal of Medicine, Vol. 2019 [2019], Iss. 3, Art. 5
https://uzjournals.edu.uz/tma/vol2019/iss3/5
Central Asian Journal of Medicine 
uzjournals.edu.uz/tma 47 2019#3 
intrauterine development in the second trimester of gestation. The study of the 
relationship of fetal and maternal DNA in blood fractions is necessary in the light of the 
fact that the successful detection of some fetal loci depends on the amount of fetal DNA 
found among DNA molecules of maternal origin [15]. Thus, for example, in most cases it 
is not possible to identify the DNA replicas inherited by the fetus from the father in the 
fraction that circulates in the DNA plasma. At the same time, when using samples 
obtained by electrophoretic separation of maternal and fetal DNA, the loci inherited by 
the fetus from the father were determined in all the cases analyzed [12]. 
Analysis of the level of fetal extracellular DNA freely circulating in plasma and 
associated with the cell surface during normal pregnancy showed that most fetal DNA 
(more than 60%) is bound to the surface of blood cells of the mother (Table 1). 
The mechanisms by which such a distribution of extracellular DNA is observed in 
the blood of pregnant women is currently unknown [12, 16]. It is likely that a higher 
concentration of extracellular DNA on the surface of blood cells, compared to plasma, is 
due to the presence of a certain degree of affinity for membrane structures and circulating 
DNA, as demonstrated previously [17, 18]. 
The study of fetal DNA levels circulating and bound to the surface of cells in the 
blood of pregnant women showed that the concentration of fetal DNA in the plasma of 
pregnant women with fetal malformations in the second trimester was 77.9 ±1.6 
copies/ml in the mother’s plasma that is 1.8-fold higher than those of pregnant women 
without fetal pathology. Whereas, the concentration of the total cell-bound fetal DNA 
was 156.2 ±4.5 copies/ml, which is 2.3-fold higher than the values of women without 
fetal pathology (Table 1).  
Table 1.  
The concentration of extracellular fetal DNA (copies/ml) in the blood of pregnant 
women with fetal malformations in the second trimester of gestation 
Study groups 
The level of 
plasma 
DNA 
The mother’s DNA bound to 
the surface of blood cells 
Total bound 
DNA 
II CSP 
Pregnant women with 
fetal pathology (n = 17) 
77.9 ±1.6 65.9 ±3.2 90.3±1.5 156.2 ±4.5■ 
Pregnant women 
without fetal pathology 
(n = 29) 
43.3 ± 1.4 31.4 ±5.2* 36.5 ±2.6* 67.9 ±3.7*■ 
 р ≤ 0.05 р < 0.01 р < 0.01 р < 0.001 
Note: * – differences between the level of fetal DNA in pregnant women with and 
without fetal pathology; ■ – differences between total bound fetal DNA and its plasma 
concentration (P < 0.001); (II - ion interactions, CSP – cell surface proteins). 
 
It should be noted that in the group of women with fetal malformations, the 
concentration of total bound fetal DNA was 2 times lower relative to its concentration in 
the plasma. 
Consequently, the concentration of fetal DNA reflects the level of proliferative / 
apoptotic changes occurring in the placental tissue and, thus, can serve as a marker of 
impaired fetal development. Indeed, in addition to the cases of miscarriage of fetuses 
with pathology, a significant increase in the level of fetal DNA is observed in such 
complications of pregnancy as preeclampsia [19], premature births [20], and placenta 
accreta [21]. 
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It is not excluded that the changing nature of the distribution of extracellular DNA 
between plasma and formed elements in women’s blood is also observed in such 
complications of pregnancy as undeveloped pregnancy, preeclampsia, as in our cases, the 
gestation of fetuses with malformations [15, 19, 20, 22]. 
In this regard, it seems appropriate to study the features of circulation of 
extracellular DNA of the mother and fetus to assess the potential use of this marker for 
non-invasive prenatal diagnosis, as well as for monitoring the course of pregnancy. 
The level of extracellular DNA of the mother in the second trimester of gestation in 
fetal pathology showed low DNA values relative to the mother’s DNA without fetal 
development pathology (Table 2). Thus, the level of maternal DNA was significantly 
reduced (in 3.1 times) in the fraction bound to the surface of blood cells. While the level 
of mother’s DNA in plasma in pregnant women with fetal pathology was only in 1.7 
times lower, in comparison with the indices of pregnant women without fetal pathology. 
This, in turn, affected the difference of the total bound DNA relative to its plasma 
concentration (P<0.001). So, if in women without fetal pathology the total bound 
extracellular DNA of the mother exceeded the values of DNA in plasma in 8.4 times, 
then in fetal pathology the difference was observed to a lesser degree (in 4.6 times). 
It should be noted that changes in the extracellular mother DNA were of opposite 
nature to changes in fetal DNA in fetal pathology, the values of which exceeded the 
parameters of women with physiological course of gestation. 
Table 2. 
The concentration of extracellular maternal DNA (copies/ml) in the blood of 
pregnant women with fetal malformations in the second trimester of gestation 
Study groups 
The level of 
plasma DNA 
The mother’s DNA bound to the 
surface of blood cells 
Total bound 
DNA 
II CSP 
Pregnant 
women with 
fetal pathology 
(n = 17) 
160.2 ± 3.5 33.0 ±2.1 705.5±4.4 738.5 ±2.6■ 
Pregnant 
women without 
fetal pathology 
(n = 29) 
272.4 ±4.9٭ 95.7 ±1.8* 2193.5 ±4.9* 2289.2 ±4.8*■ 
Note: * – differences between the level of maternal DNA in pregnant women with 
and without fetal pathology; ■ – differences between total bound fetal DNA and its 
plasma concentration (P < 0.001); (II - ion interactions, CSP – cell surface proteins). 
 
The analysis of correlation between fetal and maternal extracellular DNA in plasma 
and on the surface of red blood cells of pregnant women without fetal pathology in the 
second trimester showed that the ratio in the physiological pregnancy is higher in plasma 
and in the fraction associated with ionic interactions (II) than in the fraction of 
extracellular DNA bound to cell surface proteins (CSP). The analysis of correlation 
between fetal and maternal extracellular DNA in plasma and on the surface of blood cells 
of pregnant women with intrauterine fetal development disorders showed a similar 
correlation with only a larger difference. 
Thus, the obtained results allow to conclude that to increase the informative value 
of non-invasive diagnosis of fetal pathology at different stages of pregnancy, it seems 
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appropriate to use fractions of fetal and maternal extracellular DNA associated with the 
surface of blood cells of the mother. 
It is shown that in such developmental disorders, the concentration of the mother’s 
DNA is significantly reduced, in comparison with the norm, in the fraction of DNA 
bound to the surface of blood cells. Since fetal cells are considered as the main source of 
extracellular fetal DNA in the mother’s blood, it should be noted that the fetal DNA 
concentration, which reflects the level of proliferative/apoptotic changes occurring in 
placental tissue, can serve as a marker of disturbances in the course of gestation [22]. 
However, the use of fetal DNA in combination with other markers in programs for 
screening pregnant women increases the information content of detection of Down 
syndrome in the fetus [20]. Thus, the analysis of the level of extracellular DNA in the 
blood of pregnant women, including in combination with the assessment of the nature of 
the distribution of DNA between the plasma and the surface of the blood cells, can be 
successfully used as an additional non-invasive marker of fetal development pathology 
and gestation disorders. 
Conclusions 
1. The concentration of fetal DNA in plasma of pregnant women with fetal 
malformations in the second trimester exceeds the indicators of pregnant women without 
fetal pathology in 1.8 times. The total concentration associated with the surface of cells 
of fetal DNA in 2.3 times higher than in women without fetal pathology. 
2. The maternal DNA in fetal pathology was significantly decreased (in 3.1 times) 
in the fraction associated with the surface of blood cells, whereas the level of the 
mother’s DNA in plasma from pregnant women with fetal abnormalities was lower in 1.7 
times, in comparison with pregnant women without fetal pathology. 
3. The analysis of correlation between fetal and maternal extracellular DNA showed 
that this relationship is higher in the plasma and in the fraction associated with ionic 
interactions than in the fraction of extracellular DNA associated with cell surface proteins 
as in the physiological course of pregnancy, as in fetal abnormalities. 
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